Your Messages Inbox
Your Article Summary
See Latest ArticlesStemCells, Inc. Grants License to Stem Cell Therapeutics
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/30/06
StemCells, Inc. announced that it has entered into a license agreement with Stem Cell Therapeutics Corp., a Canadian biotechnology company engaged in treating certain central nervous system (CNS) disorders by stimulating endogenous neural stem cells. Under the agreement, Stem Cell Therapeutics (SCT) will pay StemCells up-front and license maintenance fees, as well as milestone and royalty payments
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Article Search
Sponsor